9 octobre 2013by Mario8 October 20133 June 2019Alethia Biothérapeutiques annonce la délivrance d’un brevet concernant l’utilisation d’anticorps anti-Siglec-15 Alethia PR 131009 FR Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.